Seeking Alpha
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message|
( followers)  

Do you consider yourself a value investor? For ideas on how to search for potentially undervalued stocks, we ran a screen.

We began by screening the healthcare sector for large-cap stocks, with market caps above $10 billion. We then screened for those that appear undervalued according to their EPS trends.

Based on the theoretical assumption that P/E is equal to a constant k, changes in EPS should be matched by proportionate changes in price. When they don't match up, a mispricing may have occurred.

Interactive Chart: Press Play to compare changes in analyst ratings over the last two years for the stocks mentioned below. Analyst ratings sourced from Zacks Investment Research.

We also created a price-weighted index of the stocks mentioned below, and monitored the performance of the list relative to the S&P 500 index over the last month. To access a complete analysis of this list's recent performance, click here.

Do you think these stocks should be trading higher? Use this list as a starting point for your own analysis.

1. Amgen Inc. (NASDAQ:AMGN): Develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The EPS estimate for the company's current year increased from 6.02 to 6.05 over the last 30 days, an increase of 0.5%. This increase came during a time when the stock price changed by -0.54% (from 67.93 to 67.56 over the last 30 days).

2. AstraZeneca PLC (NYSE:AZN): Develops, and commercializes prescription medicines for cardiovascular, gastrointestinal, infection, neuroscience, oncology, and respiratory and inflammation diseases worldwide. The EPS estimate for the company's current year increased from 6.06 to 6.08 over the last 30 days, an increase of 0.33%. This increase came during a time when the stock price changed by -6.11% (from 48.15 to 45.21 over the last 30 days).

3. GlaxoSmithKline plc (NYSE:GSK): Engages in the discovery, development, manufacture, and marketing of pharmaceutical products, over the counter medicines, and health-related consumer products worldwide. The EPS estimate for the company's current year increased from 3.44 to 3.7 over the last 30 days, an increase of 7.56%. This increase came during a time when the stock price changed by 1.1% (from 44.54 to 45.03 over the last 30 days).

4. Sanofi-Aventis (NYSE:SNY): Engages in the discovery, development, and distribution of therapeutic solutions to improve the lives of everyone. The EPS estimate for the company's current year increased from 3.95 to 4.38 over the last 30 days, an increase of 10.89%. This increase came during a time when the stock price changed by 2.53% (from 37.13 to 38.07 over the last 30 days).

5. Zimmer Holdings, Inc. (NYSE:ZMH): Engages in the design, development, manufacture, and marketing of orthopaedic reconstructive implants, spinal and trauma devices, dental implants, and related surgical products. The EPS estimate for the company's current year increased from 5.24 to 5.27 over the last 30 days, an increase of 0.57%. This increase came during a time when the stock price changed by -0.67% (from 60.75 to 60.34 over the last 30 days).

*EPS data sourced from Yahoo Finance, all other data sourced from Finviz.

Source: 5 Large-Cap Healthcare Stocks Undervalued By EPS Trends